NKGen Biotech, Inc. entered into a second amendment to a forward purchase agreement with Meteora Capital Partners, increasing the Prepayment Shortfall by $500,000.
AI Assistant
NKGEN BIOTECH INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.